U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C22H31NO3.ClH
Molecular Weight 393.947
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RCC-36

SMILES

Cl.CCNCC#CC(C)(C)OC(=O)C(O)(C1CCCCC1)C2=CC=CC=C2

InChI

InChIKey=AEPBOUHKRSABGU-UHFFFAOYSA-N
InChI=1S/C22H31NO3.ClH/c1-4-23-17-11-16-21(2,3)26-20(24)22(25,18-12-7-5-8-13-18)19-14-9-6-10-15-19;/h5,7-8,12-13,19,23,25H,4,6,9-10,14-15,17H2,1-3H3;1H

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Comparison of the effects of novel antimuscarinic drugs on human detrusor smooth muscle.
2000-10
Pharmacologic actions of temiverine (p-INN) and its active metabolite, RCC-36, on isolated human urinary bladder muscle.
1998-05
Patents
Name Type Language
RCC-36
Code English
RCC36
Preferred Name English
(±)-4-ETHYLAMINO-1,1-DIMETHYLBUT-2-YN-1-YL 2-CYCLOHEXYL-2-HYDROXY-2-PHENYLACETATE MONOHYDROCHLORIDE
Systematic Name English
BENZENEACETIC ACID, .ALPHA.-CYCLOHEXYL-.ALPHA.-HYDROXY-, 4-(ETHYLAMINO)-1,1-DIMETHYL-2-BUTYN-1-YL ESTER, HYDROCHLORIDE (1:1)
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID50926529
Created by admin on Mon Mar 31 21:32:28 GMT 2025 , Edited by admin on Mon Mar 31 21:32:28 GMT 2025
PRIMARY
FDA UNII
0FUM3H8670
Created by admin on Mon Mar 31 21:32:28 GMT 2025 , Edited by admin on Mon Mar 31 21:32:28 GMT 2025
PRIMARY
PUBCHEM
154339
Created by admin on Mon Mar 31 21:32:28 GMT 2025 , Edited by admin on Mon Mar 31 21:32:28 GMT 2025
PRIMARY
CAS
129927-37-3
Created by admin on Mon Mar 31 21:32:28 GMT 2025 , Edited by admin on Mon Mar 31 21:32:28 GMT 2025
PRIMARY